T1	Participants 28 74	completely resected non-small-cell lung cancer
T2	Participants 416 584	Patients with completely resected (stage IB, II, or IIIA) NSCLC stratified by stage, histology, sex, postoperative radiotherapy, and chemotherapy were randomly assigned
T3	Participants 765 787	1,242 planned patients
